semaglutide 25 Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) and reduced Novo Nordisk has received FDA

Available at: (Accessed November 8, 2021)

Theyre controlled by hormones and signals in the body, and the struggle isnt just about saying no , its about your body not saying enough. Every time you eat, your body should send two clear signals: When either of these signals is disrupted, your body doesn't recognise that it's had enough

Get in touch with our team to start a conversation.

General practitioners are increasingly initiating these therapies, often in response to patient demand or as part of broader cardiometabolic risk management

Extended stability testing at 5, 25, 40, 60, and 80 degrees Celsius revealed that while semaglutide remained stable for 3 hours even at 80 degrees Celsius under stress conditions, real-world storage demands consistent cold temperatures for long-term stability

Food and Drug Administration (FDA) as a weightloss drug, Trulicity may be prescribed offlabel for weight management in people who are overweight or obese